|
VAMP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.570800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097220E-01 |
| Normal-vs-Stage2 |
8.068800E-01 |
| Normal-vs-Stage3 |
3.210800E-01 |
| Normal-vs-Stage4 |
7.353000E-01 |
| Stage1-vs-Stage2 |
3.611600E-01 |
| Stage1-vs-Stage3 |
6.550800E-01 |
| Stage1-vs-Stage4 |
3.637800E-01 |
| Stage2-vs-Stage3 |
5.882200E-01 |
| Stage2-vs-Stage4 |
9.654400E-01 |
| Stage3-vs-Stage4 |
5.916400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.499700E-02 |
| Normal-vs-AfricanAmerican |
5.469700E-02 |
| Normal-vs-Asian |
3.444200E-01 |
| Caucasian-vs-AfricanAmerican |
1.882630E-01 |
| Caucasian-vs-Asian |
8.069000E-01 |
| AfricanAmerican-vs-Asian |
2.057800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.637400E-01 |
| Normal-vs-Female |
9.555700E-02 |
| Male-vs-Female |
2.085400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.813700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.351200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.959200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.737400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.687210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.725900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.543000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.068200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.856800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.196600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.353200E-01 |
| Classical-VS-Follicular |
3.755500E-04 |
| Classical-VS-Other |
6.773600E-02 |
| Classical-VS-Normal |
1.105870E-02 |
| Tall-VS-Follicular |
4.255900E-02 |
| Tall-VS-Other |
1.192800E-01 |
| Tall-VS-Normal |
2.202400E-01 |
| Follicular-VS-Other |
7.480000E-01 |
| Follicular-VS-Normal |
2.595600E-01 |
| Other-VS-Normal |
2.783400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.830800E-01 |
| Normal-vs-N1 |
4.898600E-01 |
| N0-vs-N1 |
2.127200E-01 |
|
|
